BioSpace News Archive

TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced today that members of the management team will present virtually at the upcoming Cowen 41 st Annual Healthcare Conference. Managem

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, announced today that its management team will present at the following upcoming investor conferences:

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that it will release fourth quarter and full year 2020 financial results after the market closes on Tuesday, February 23, 2021.

Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will release its fourth quarter and full-year 2020 financial results and provide a corporate update on Tuesday, February 23, 2021, after the close of the U.S. financial markets.

Entresto is the first and only therapy approved in the US to treat patients diagnosed with guideline-defined heart failure to include both those with heart failure with reduced ejection fraction (HFrEF) and many with heart failure with preserved ejection fraction (HFpEF)(1-3)

Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF) (Frankfurt: P731) announced today that it will be presenting at the Winter Wonderland Conference, hosted by The MicroCap Rodeo, being held virtually on February 16 th – February 19 th , 2021. ,

LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it is participating in four upcoming investor conferences. David Roberts, President, is scheduled to present at the following virtual conferences: SVB Leerink’s 10th Annual Global Healthcare Conference on Friday, February 26, 2021, at 8:40 AM EST Barclays Global Healthcare Conference on Tuesday, March 9, 2021, at 1:50 PM EST 33 rd Annual Roth Conference on Monday, March 15, 20

Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced the closing of its previously announced registered direct offering of 4,222,288 shares of its common stock, at a purchase price of $1.75 per share,

Contec, Inc., a Spartanburg, SC -based manufacturer of critical cleaning products for the pharmaceutical, med device and healthcare industries and New Jersey --based corporate headquarters, Mannington Commercial, one of the world’s leading manufacturers of fine flooring, have announced an exclusive alliance in their efforts t

JEOL Ltd. announces the release of JMS-T2000GC “AccuTOF GC-Alpha”, the latest model of the successful AccuTOF GC series gas chromatograph – time-of-flight mass spectrometers, to be released in February 2021.